DOT Drug Testing After January 1, 2018 – Still a 5-Panel
Since January 1st, we have required confirmation testing for 14 drugs under a 5‑panel test. Broken out, here is what DOT drug testing looks like:
- Marijuana (THC)
- 6-AM (heroin)
- Phencyclidine (PCP)
For DOT testing, what does this mean for collectors, laboratories, MROs, and employers after January 1st ,2018?
- Collectors will continue to check the 5-panel box in Step 1 of the CCF: That is, the box specified for “THC, COC, PCP, OPI, AMP.”
- Laboratories will:
- continue to report to MROs the specific drugs / drug metabolites they confirm as positive, and laboratories will add hydrocodone, hydromorphone, oxycodone, and oxymorphone confirmed positives, as appropriate.
- on their semi-annual reports to DOT and their semi-annual reports to employers add: hydrocodone; hydromorphone; oxycodone; and oxymorphone confirmed positive totals, as appropriate, under Opioids.
- MROs will continue to report to employers the specific drugs / drug metabolite they verify as positive; and MROs will add hydrocodone, hydromorphone, oxycodone, and oxymorphone verified positives, as appropriate.
- Employers will continue to provide – on their annual MIS reports – the number of verified positive drug test results in each testing category (i.e., Marijuana, Cocaine, Amphetamines, Opioids, and PCP).